If you didn't measure a baseline, you can't tell if the peptide worked

Escalating a peptide dose because "nothing's happening yet" is the most common mistake in the space. The problem isn't the dose. It's that without a baseline and a set of outcome variables, you have no way to know whether nothing is happening, or whether plenty is happening and you just can't see it.

This is the attribution problem. Most peptide tracking in the wild is bodyweight plus a vibe. That gives you one noisy number and a feeling. When you then raise the dose, you've changed the input without ever having measured the output, so whatever happens next, good, bad, or nothing, can't be traced back to anything.

Why escalating blind makes it worse, not clearer

Dose escalation adds variables, it doesn't remove them. A few reasons it defeats attribution specifically:

• Buildup lags the change. Retatrutide (still investigational) has a half-life around 6 days, so the drug keeps accumulating for 3 to 4 weeks before blood levels plateau. Raise the dose at week 2 because you're impatient and you've stacked two moving concentrations on top of each other. The two never cleanly separate.
• Side effects scale with dose. GI issues, resting heart rate creep, sleep disruption, and libido changes all tend to get worse at higher doses. Escalate before you've logged a baseline and you can't tell whether a new symptom is the compound, the dose jump, or something unrelated in your life that week.
• Muscle loss hides inside weight loss. On a GLP-1, the scale dropping looks like success. Without body composition, you can't see whether you're losing fat or lean mass, and lean mass is the failure mode.

Every one of those is an attribution failure. The fix is the same in all three: measure before you touch the dose.

A baseline is four things, taken before you start

You cannot compute a change if you never recorded the starting point. The minimum viable baseline:

1. A fasted blood panel. HbA1c, fasting insulin, HOMA-IR, ApoB, hs-CRP, a lipid panel. This is the foundation. Without it, nothing later has a reference.
2. IGF-1, if you're running anything on the growth-hormone axis (CJC-1295, ipamorelin, MK-677, sermorelin, tesamorelin). It's the single most reliable readout for that class. If IGF-1 hasn't moved by end of cycle, the peptide didn't do what you paid for.
3. A DEXA scan. It separates fat, lean, visceral, and bone. Bodyweight tells you almost nothing about that split, which is most of what a peptide actually changes about your body. Pre-cycle and end-of-cycle, minimum.
4. A hormonal panel for longer protocols: free and total testosterone, AM cortisol, TSH, prolactin. This is what catches HPA or thyroid disruption you'd otherwise miss.

These are numbers you review with a clinician, not a self-prescribed plan. The point is that they exist before the intervention does.

Then track the outcome variables during the cycle

Baseline tells you where you started. Outcome variables tell you what's moving, in time to act on it:

• HRV, resting heart rate, and sleep, continuously, from a wearable. Some peptides nudge resting heart rate up a couple bpm, and only 24/7 monitoring catches that against your own baseline.
• A CGM while titrating any GLP-1, then two-week spot checks each quarter. It catches glucose shifts that a quarterly blood draw misses entirely.
• Protein and calories, logged daily, especially on a GLP-1. Appetite suppression is the point; muscle loss is the price if protein quietly drops and you don't notice.
• Subjective scales turned into numbers: sleep quality, fatigue, sexual function. The vibe, but recorded, so week 6 is actually comparable to week 1.
• A dosing log: what you injected, when, which site, the reconstitution math. Attribution is impossible if you can't reconstruct what you actually took.

The one rule

Change one variable at a time, and don't change it until you can measure the thing it's supposed to move. That's the whole discipline. A dose you escalated blind isn't a protocol. It's a guess with needles.

If you're still choosing a source before any of this matters, start with how to vet a vendor, then read what a lab result actually proves and what purity number is good enough, so the compound you're measuring is the one on the label. More in the feed.